IEMbase 0790: ADA2-related adenosine deaminase 2 deficiency
Scope
| Field | Value |
|---|---|
| IEMbase ID | 790 |
| Nosology | 16.2.08.01 |
| Nosology code | IEM0014 |
| Gene | ADA2 |
| External IDs | OMIM:607575; ORPHA:404553 |
| Generated mapping | UNMAPPED; best lexical candidate Deficiency_of_Adenosine_Deaminase_2.yaml |
| Candidate DisMech targets | Deficiency_of_Adenosine_Deaminase_2.yaml |
| Review date | 2026-07-11 |
IEMbase phenotype signal
IEMbase labels this autosomal recessive record as ADA2-related adenosine deaminase 2 deficiency, with alternate name childhood-onset polyarteritis nodosa and abbreviation CECR1. The IEMbase signal is sparse but characteristic: very low plasma/deoxyadenosine deaminase activity, polyarteritis nodosa across age groups, and adult Sneddon syndrome.
DisMech phenotype coverage
Deficiency_of_Adenosine_Deaminase_2.yaml is the correct local target. It
models biallelic ADA2/CECR1 loss of function, markedly reduced ADA2 activity,
endothelial injury, vasculopathy, myeloid inflammatory dysregulation, emerging
lysosomal DNA-editing/TLR9 immune-sensing biology, recurrent fever, livedo
racemosa, early-onset ischemic and hemorrhagic stroke, polyarteritis
nodosa-like vasculitis, hepatosplenomegaly, immunodeficiency, cytopenias,
anti-TNF therapy, and hematopoietic stem cell transplantation.
Concordance and completeness
Judgement: false negative; exact local disease coverage exists.
The gene, CECR1 synonym, recessive inheritance, low enzyme activity, and
polyarteritis nodosa identity are concordant. IEMbase's Sneddon syndrome row is
best handled as a phenotype/overlap prompt within ADA2 vasculopathy, not as a
reason to map the record to the separate local Sneddon_syndrome.yaml entry.
The local DADA2 entry is much richer for mechanism, stroke, livedo, immune, and
therapy coverage.
Curation actions
- Treat
Deficiency_of_Adenosine_Deaminase_2.yamlas exact local coverage for IEMbase 0790. - Preserve childhood-onset PAN and CECR1 as alternate naming for DADA2.
- Consider reviewing whether Sneddon-like vasculopathy should be added as an explicit phenotype or discussion note in the local DADA2 entry.